In addition to our on-going partnership with the University of Alabama, Birmingham, we have collaborated with many major research universities on a range of cutting-edge biomedical projects. We believe that on-going dialogs between labs, departments and institutions is the best way to optimize resources, make new discoveries and advance the science.
For more information on our faculty and their current research efforts, please see the departmental pages for Oncology, Neuroscience, Infectious Disease, High-Throughput Screening, and Medicinal Chemistry.
The Drug Discovery Division has a long history of working with pharmaceutical and biotechnology companies of all sizes on programs of mutual interest. Our capabilities in specialized high-throughput screening, assay development and medicinal chemistry, combined with our deep domain expertise in oncology, infectious disease and neuroscience make us a partner of choice for many companies.
It is important to us that partnerships with industry be both meaningful and mutually beneficial. In support of this goal, we are very flexible with our partnership structures, which can range from funded research collaborations to joint drug development programs to full licensing agreements for our internal pipeline programs.